Nuwellis Inc (NUWE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nuwellis Inc (NUWE) has a cash flow conversion efficiency ratio of -0.804x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.15 Million) by net assets ($3.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NUWE market cap overview for the company's overall valuation and market capitalisation.
Nuwellis Inc - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Nuwellis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Nuwellis Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nuwellis Inc ranked by their cash flow conversion efficiency. Explore NUWE cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ENvue Medical Inc.
NASDAQ:FEED
|
-0.087x |
|
CAT STRATEGIC MET.
F:8CHA
|
-0.016x |
|
Prima Moda SA
WAR:PMA
|
0.241x |
|
Arcandor AG
DU:ARO
|
N/A |
|
PDG Realty S.A. Empreendimentos e Participações
SA:PDGR3
|
-0.006x |
|
XXL Energy Corp
V:XL
|
-0.009x |
|
Gemfields Plc
LSE:GEM
|
0.044x |
|
Lucky Minerals Inc
V:LKY
|
0.000x |
Annual Cash Flow Conversion Efficiency for Nuwellis Inc (2003–2024)
The table below shows the annual cash flow conversion efficiency of Nuwellis Inc from 2003 to 2024. View NUWE live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $6.53 Million | $-9.59 Million | -1.469x | +73.71% |
| 2023-12-31 | $3.21 Million | $-17.94 Million | -5.586x | -355.66% |
| 2022-12-31 | $12.36 Million | $-15.15 Million | -1.226x | -78.27% |
| 2021-12-31 | $25.95 Million | $-17.84 Million | -0.688x | +32.29% |
| 2020-12-31 | $16.32 Million | $-16.57 Million | -1.016x | +87.65% |
| 2019-12-31 | $1.99 Million | $-16.37 Million | -8.225x | -235.31% |
| 2018-12-31 | $5.94 Million | $-14.56 Million | -2.453x | -234.14% |
| 2017-12-31 | $16.24 Million | $-11.92 Million | -0.734x | +92.08% |
| 2016-12-31 | $1.76 Million | $-16.29 Million | -9.273x | -390.92% |
| 2015-12-31 | $12.17 Million | $-22.99 Million | -1.889x | -143.69% |
| 2014-12-31 | $29.21 Million | $-22.64 Million | -0.775x | -130.92% |
| 2013-12-31 | $51.73 Million | $-17.36 Million | -0.336x | +66.78% |
| 2012-12-31 | $12.95 Million | $-13.08 Million | -1.010x | +64.52% |
| 2011-12-31 | $4.60 Million | $-13.09 Million | -2.848x | -85.26% |
| 2010-12-31 | $4.02 Million | $-6.18 Million | -1.537x | 0.00% |
| 2009-12-31 | $4.02 Million | $-6.18 Million | -1.537x | +59.74% |
| 2008-12-31 | $1.64 Million | $-6.25 Million | -3.819x | -314.53% |
| 2007-12-31 | $9.51 Million | $-8.76 Million | -0.921x | +25.15% |
| 2006-12-31 | $6.89 Million | $-8.48 Million | -1.231x | -14.82% |
| 2005-12-31 | $4.38 Million | $-4.70 Million | -1.072x | -61.61% |
| 2004-12-31 | $7.30 Million | $-4.84 Million | -0.663x | +92.54% |
| 2003-12-31 | $139.47K | $-1.24 Million | -8.886x | -- |
About Nuwellis Inc
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The compan… Read more